Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN

clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov

Details

Instance of: clinical trial
Main subject: cancer immunotherapy, laryngeal neoplasm, neoplasm of oropharynx
maximum age: 75
minimum age: 18
research site: Hospital Feldkirch
study type: interventional study

Nothing in the MetaHistoryBook collection references this item yet.